Transaction #25296 · Form 4 · 0000905148-25-004492
RIGEL PHARMACEUTICALS INC · Exercise / conversion · Common Stock
RIGEL PHARMACEUTICALS INC · Transacted December 22, 2025 · Filed December 29, 2025
What does this filing report?
An SEC Form 4 filing for RIGEL PHARMACEUTICALS INC records an exercise / conversion involving Common Stock on December 22, 2025. The reported quantity was 2,846. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- RIGEL PHARMACEUTICALS INC
- Company CIK
- 0001034842
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 2,846
- Reported price
- 24.2 · See footnotes
- Reference value
- 68,873.2
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 62,568
- Ownership description
- Not reported
- SEC acceptance time
- Dec 29, 2025, 8:06 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Schorno Dean L ↗
EVP & Chief Financial Officer
CIK 0001509688
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- F2
- Includes 500 shares of common stock acquired under the Issuer's stock purchase plan.
- F3
- The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019, subject to the reporting person's continuous service to the Issuer through each such period.
- F4
- The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the Issuer through each such period.
- F5
- The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.